Picture of Gamida Cell logo

GMDAQ — Gamida Cell News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Gamida Cell Ltd expected to post a loss of 15 cents a share - Earnings Preview

* Gamida Cell Ltd  GMDA.OQ   GMDA.O  is expected to show a
rise in
quarterly revenue when it reports  results on March 27 for the
period ending December 31 2023
    * The Jerusalem Israel-based   company is expected to report
revenue of $1.064 million, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Gamida Cell Ltd is for a
loss
of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Gamida Cell
Ltd
is $5.00​, above​ its last closing price of $0.40. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.18       -0.17      -0.01     Beat    94.1
 Jun. 30 2023  -0.19       -0.19      -0.31     Missed  -59.6
 Mar. 31 2023  -0.27       -0.27      -0.27     Met     1.5​
 Dec. 31 2022              -0.25      -0.30     Missed  -20
 ​​Sep.        -0.31       -0.31      -0.29     Beat    5.2
 30 2022                                                
 Jun. 30 2022  -0.29       -0.29      -0.31     Missed  -6.2​
 Mar. 31 2022  -0.34       -0.34      -0.34     Met     0
 Dec. 31 2021  -0.40       -0.40      -0.52     Missed  -28.4
 This summary was machine generated March 22 at 21:04 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Gamida Cell

See all news